Title: Generic drug in Indonesia: why physicians and pharmacists matters

Authors: Amelia Amelia; Ronald Ronald

Addresses: Faculty of Business School, Universitas Pelita Harapan Surabaya, Tokyo Tower 6th floor, City of Tomorrow Superblok, Jl. Jend. A. Yani No. 288, Waru-Surabaya 60234, Indonesia ' Faculty of Business School, Universitas Pelita Harapan Surabaya, Tokyo Tower 6th floor, City of Tomorrow Superblok, Jl. Jend. A. Yani No. 288, Waru-Surabaya 60234, Indonesia

Abstract: Since 2014, Indonesia began imposing the National Health Insurance program. One of the goals of implementing the program is to increase the use of generic drugs. This action was done to respond the low use of generic drugs, which is around 11%, in 2011 (World Bank, 2008). Therefore, this study tried to examine the factors that influence the purchase intention of generic drugs based on the information from physicians and pharmacists. Also the overall information risk with experience was used as moderating variable. The research sample for this includes 400 respondents. The questionnaires were distributed from September 2014 until December 2015. The questionnaire distribution takes a relatively long time due to the very small number of generic drug users were available. The result shows that physician information have the biggest effect on the purchase intention of generic drugs, and that experience has a significant effect as moderating variable.

Keywords: generic drugs; physician information; pharmacist information; experience; Indonesia.

DOI: 10.1504/IJMEF.2018.093796

International Journal of Monetary Economics and Finance, 2018 Vol.11 No.3, pp.307 - 315

Received: 11 Dec 2016
Accepted: 05 Jan 2017
Published online: 06 Aug 2018 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article